Get started
Author

Kristian Unger

Observed names: K Unger, K. Unger, KRISTIAN UNGER, Kristian M. Unger, Kristian Unger,, Unger, Kristian
Institutions: German Cancer Research Center, Helmholtz Munich, LMU Klinikum, German Center for Diabetes Research, Deutsches Konsortium für Translationale Krebsforschung, Ludwig-Maximilians-Universität München
Observed institutions: University of St Andrews, German Cancer Research Center, Hammersmith Hospital, Helmholtz-Zentrum Dresden-Rossendorf, Helmholtz Munich, LMU Klinikum, Klinik und Poliklinik für Strahlentherapie und Radioonkologie, OncoRay, German Center for Diabetes Research, University Hospital Carl Gustav Carus, Deutsches Konsortium für Translationale Krebsforschung, Institute of Computational Biology, German Cancer Consortium (DKTK) Dresden, Imperial College London, Technische Universität Dresden, Ludwig-Maximilians-Universität München
ORCID: 0000-0002-0374-2320
Observed ORCID: 0000-0002-0374-2320
OpenAlex ID: A5050705404
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
2021 · Dominik Pfister, Nicolás Gonzalo Núñez, et al. · Nature · 1,280
PDF
Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes
2014 · Monika Julia Wolf, Arlind Adili, et al. · Cancer Cell · 679
PDF
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
2015 · Shlomi Finkin, Detian Yuan, et al. · Nature Immunology · 433
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
2018 · Sebastian Mueller, Thomas Engleitner, et al. · Nature · 431
PDF
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
2019 · Mohsen Malehmir, Dominik Pfister, et al. · Nature Medicine · 395
Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment
2015 · Xueru Mu, Regina Español-Suñer, et al. · Journal of Clinical Investigation · 215
PDF
Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS
2017 · Detian Yuan, Shan Huang, et al. · Cancer Cell · 197
RET/Papillary Thyroid Cancer Rearrangement in Nonneoplastic Thyrocytes: Follicular Cells of Hashimoto’s Thyroiditis Share Low-Level Recombination Events with a Subset of Papillary Carcinoma
2006 · Kerry J. Rhoden, Kristian Unger, et al. · The Journal of Clinical Endocrinology & Metabolism · 197
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice
2015 · Julia Weber, Rupert Öllinger, et al. · Proceedings of the National Academy of Sciences · 192
PDF
Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
2016 · Roman Maresch, Sebastian Mueller, et al. · Nature Communications · 166
PDF
A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development
2017 · Yannick Boege, Mohsen Malehmir, et al. · Cancer Cell · 154
PDF
High resolution array-CGH analysis of single cells
2006 · Heike Fiegler, Jochen B. Geigl, et al. · Nucleic Acids Research · 149
PDF
A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas
2012 · G Dom, M Tarabichi, et al. · British Journal of Cancer · 147
PDF
Sublethal necroptosis signaling promotes inflammation and liver cancer
2023 · Mihael Vucur, Ahmed Ghallab, et al. · Immunity · 136
PDF
Heterogeneity in the Distribution ofRET/PTCRearrangements within Individual Post-Chernobyl Papillary Thyroid Carcinomas
2004 · Kristian Unger, Horst Zitzelsberger, et al. · The Journal of Clinical Endocrinology & Metabolism · 133
RIP3 Inhibits Inflammatory Hepatocarcinogenesis but Promotes Cholestasis by Controlling Caspase-8- and JNK-Dependent Compensatory Cell Proliferation
2013 · Mihael Vucur, Florian Reisinger, et al. · Cell Reports · 128
PDF
Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
2015 · I Summerer, K Unger, et al. · British Journal of Cancer · 124
PDF
MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells
2018 · Michael Kleemann, Helga Schneider, et al. · Scientific Reports · 107
PDF
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
2023 · Elena Kotsiliti, Valentina Leone, et al. · Journal of Hepatology · 106
PDF
Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
2013 · Isolde Summerer, Maximilian Niyazi, et al. · Radiation Oncology · 105
PDF
Very‐low‐carbohydrate diet enhances human T‐cell immunity through immunometabolic reprogramming
2021 · Simon Hirschberger, Gabriele Strauß, et al. · EMBO Molecular Medicine · 101
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients
2021 · Run Shi, Xuanwen Bao, et al. · Theranostics · 98
CFAssay: statistical analysis of the colony formation assay
2015 · Herbert Braselmann, Agata Michna, et al. · Radiation Oncology · 94
PDF
Simultaneous β1 integrin-EGFR Targeting and Radiosensitization of Human Head and Neck Cancer
2015 · Iris Eke, Katja Zscheppang, et al. · JNCI Journal of the National Cancer Institute · 91
PDF
EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers
2018 · Min Pan, Henrik Schinke, et al. · PLoS Biology · 85
PDF
Works count: 271
Citation count: 8,917
H-index: 45
I10-index: 109
Year
Topic
Type